Current Assets
Short-Term Investments
Bristol-Myers Squibb Short-Term Investments increased by 96.6% to $912.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.6%, from $907.00M to $912.00M. Over 5 years (FY 2020 to FY 2025), Short-Term Investments shows a downward trend with a -18.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase suggests the company is effectively deploying excess cash to earn returns; a decrease may indicate cash usage for operations or acquisitions.
Detailed definition
These are marketable securities and other financial instruments that the company intends to hold for more than three mon...
Peer comparison
Common for companies with significant cash reserves and active treasury management.
Metric ID:
short_term_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.95B | $2.12B | $2.99B | $2.60B | $2.48B | $1.29B | $130.00M | $274.00M | $358.00M | $171.00M | $816.00M | $340.00M | $360.00M | $204.00M | $513.00M | $907.00M | $1.00B | $776.00M | $464.00M | $912.00M |
| QoQ Change | — | +9.1% | +40.7% | -13.0% | -4.7% | -47.8% | -89.9% | +110.8% | +30.7% | -52.2% | +377.2% | -58.3% | +5.9% | -43.3% | +151.5% | +76.8% | +10.7% | -22.7% | -40.2% | +96.6% |
| YoY Change | — | — | — | — | +27.3% | -39.1% | -95.6% | -89.5% | -85.6% | -86.8% | +527.7% | +24.1% | +0.6% | +19.3% | -37.1% | +166.8% | +178.9% | +280.4% | -9.6% | +0.6% |
Range$130.00M – $2.99B
CAGR-14.7%
Avg YoY Growth+48.9%
Median YoY Growth+0.6%
Short-Term Investments at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's short-term investments?
- Bristol-Myers Squibb (BMY) reported short-term investments of $912.00M in Q1 2026.
- How has Bristol-Myers Squibb's short-term investments changed year-over-year?
- Bristol-Myers Squibb's short-term investments increased by 0.6% year-over-year, from $907.00M to $912.00M.
- What is the long-term trend for Bristol-Myers Squibb's short-term investments?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's short-term investments has grown at a -18.4% compound annual growth rate (CAGR), from $1.29B to $464.00M.
- What does short-term investments mean?
- Liquid investments maturing between three months and one year.